bpc-157 fda warning compounding issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of fda warning unapproved peptide products

It is one of the twelve peptides the FDA removed from the list that restricted compounding in April 2026, and one of seven under formal advisory review on July 2324, 2026

Although a clear mechanistic perspective is lacking, it can be conceptualized that gut microbial dysbiosis (and its metabolites) modulates innate and adaptive immune players by recruiting immune secreting cells from the appendix, thereby priming the immune system for an enhanced inflammatory response and a possible source of -synuclein misfolding (Masahata et al., 2014

This response was more limited to the gut, so may have helped more in people with gastrointestinal issues like irritable bowel syndrome and Crohns

11 In humans, the administration of GLP-1RAs reduces appetite, decreases energy intake, and increases satiety

Some people may experience allergic reactions to the HCG hormone, leading to symptoms such as dizziness, headaches, hives, and breathing difficulties

AOD9604 is a modified fragment of human growth hormone, primarily researched for its lipolytic (fat-reducing) properties without promoting cell proliferation or insulin resistance